These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
575 related articles for article (PubMed ID: 32379755)
41. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. Freisling H; Viallon V; Lennon H; Bagnardi V; Ricci C; Butterworth AS; Sweeting M; Muller D; Romieu I; Bazelle P; Kvaskoff M; Arveux P; Severi G; Bamia C; Kühn T; Kaaks R; Bergmann M; Boeing H; Tjønneland A; Olsen A; Overvad K; Dahm CC; Menéndez V; Agudo A; Sánchez MJ; Amiano P; Santiuste C; Gurrea AB; Tong TYN; Schmidt JA; Tzoulaki I; Tsilidis KK; Ward H; Palli D; Agnoli C; Tumino R; Ricceri F; Panico S; Picavet HSJ; Bakker M; Monninkhof E; Nilsson P; Manjer J; Rolandsson O; Thysell E; Weiderpass E; Jenab M; Riboli E; Vineis P; Danesh J; Wareham NJ; Gunter MJ; Ferrari P BMC Med; 2020 Jan; 18(1):5. PubMed ID: 31918762 [TBL] [Abstract][Full Text] [Related]
42. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. Jani BD; Nicholl BI; McQueenie R; Connelly DT; Hanlon P; Gallacher KI; Lee D; Mair FS Europace; 2018 Nov; 20(FI_3):f329-f336. PubMed ID: 29112751 [TBL] [Abstract][Full Text] [Related]
43. Associations of dietary magnesium intake with the risk of atherosclerotic cardiovascular disease and mortality in individuals with and without type 2 diabetes: A prospective study in the UK Biobank. Huang R; Kong X; Geng R; Wu J; Li J; Gu Y; Wu Y; You D; Zhao Y; Ni S; Zhong Z; Bai J Diabetes Metab; 2024 Sep; 50(5):101554. PubMed ID: 38950854 [TBL] [Abstract][Full Text] [Related]
44. Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank. Sun T; Yang J; Lei F; Huang X; Liu W; Zhang X; Lin L; Sun L; Xie X; Zhang XJ; Cai J; She ZG; Xu C; Li H Cardiovasc Diabetol; 2024 Jul; 23(1):233. PubMed ID: 38965574 [TBL] [Abstract][Full Text] [Related]
46. Sociodemographic characteristics and longitudinal progression of multimorbidity: A multistate modelling analysis of a large primary care records dataset in England. Chen S; Marshall T; Jackson C; Cooper J; Crowe F; Nirantharakumar K; Saunders CL; Kirk P; Richardson S; Edwards D; Griffin S; Yau C; Barrett JK PLoS Med; 2023 Nov; 20(11):e1004310. PubMed ID: 37922316 [TBL] [Abstract][Full Text] [Related]
47. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank. Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262 [TBL] [Abstract][Full Text] [Related]
48. Relationship between HbA1c and all-cause mortality in older patients with insulin-treated type 2 diabetes: results of a large UK Cohort Study. Anyanwagu U; Mamza J; Donnelly R; Idris I Age Ageing; 2019 Mar; 48(2):235-240. PubMed ID: 30615050 [TBL] [Abstract][Full Text] [Related]
49. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. Fraser SD; Roderick PJ; May CR; McIntyre N; McIntyre C; Fluck RJ; Shardlow A; Taal MW BMC Nephrol; 2015 Dec; 16():193. PubMed ID: 26620131 [TBL] [Abstract][Full Text] [Related]
50. Effect modification in the association between glycated haemoglobin and cardiovascular disease and mortality in patients with type 2 diabetes. van Munster SN; van der Graaf Y; de Valk HW; Visseren FL; Westerink J; Diabetes Obes Metab; 2017 Mar; 19(3):320-328. PubMed ID: 27807924 [TBL] [Abstract][Full Text] [Related]
51. Association between risk, duration and cause of hospitalisations in people with rheumatoid arthritis and multimorbidity in the UK Biobank and Scottish Early Rheumatoid Arthritis (SERA) cohorts: Longitudinal observational study. Morton FR; Jani BD; Mair FS; McLoone P; Canning J; Macdonald S; McQueenie R; Siebert S; Nicholl BI Semin Arthritis Rheum; 2023 Feb; 58():152130. PubMed ID: 36459724 [TBL] [Abstract][Full Text] [Related]
52. Subtypes of Type 2 Diabetes and Incident Cardiovascular Disease Risk: UK Biobank and All of Us Cohorts. Xue Q; Li X; Wang X; Ma H; Heianza Y; Qi L Mayo Clin Proc; 2023 Aug; 98(8):1192-1204. PubMed ID: 37422735 [TBL] [Abstract][Full Text] [Related]
53. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification. Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131 [TBL] [Abstract][Full Text] [Related]
54. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes. Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048 [TBL] [Abstract][Full Text] [Related]
55. Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort study. Tran J; Norton R; Conrad N; Rahimian F; Canoy D; Nazarzadeh M; Rahimi K PLoS Med; 2018 Mar; 15(3):e1002513. PubMed ID: 29509757 [TBL] [Abstract][Full Text] [Related]
56. Association of type 1 diabetes and age at diagnosis of type 2 diabetes with brain volume and risk of dementia in the UK Biobank: A prospective cohort study of community-dwelling participants. Shang X; Hill E; Liu J; Zhu Z; Ge Z; Wang W; He M Diabet Med; 2023 Feb; 40(2):e14966. PubMed ID: 36177651 [TBL] [Abstract][Full Text] [Related]
57. Smoking timing, genetic susceptibility and the risk of incident type 2 diabetes: A cohort study from the UK Biobank. Hu Y; Li X; Wang X; Ma H; Zhou J; Tang R; Kou M; Heianza Y; Liang Z; Qi L Diabetes Obes Metab; 2024 Jul; 26(7):2850-2859. PubMed ID: 38618988 [TBL] [Abstract][Full Text] [Related]
58. Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. Luijks H; Schermer T; Bor H; van Weel C; Lagro-Janssen T; Biermans M; de Grauw W BMC Med; 2012 Oct; 10():128. PubMed ID: 23106808 [TBL] [Abstract][Full Text] [Related]
59. Temporal trends in co-morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK. Ling J; Koye D; Buizen L; Khunti K; Montvida O; Paul SK Diabetes Obes Metab; 2021 May; 23(5):1150-1161. PubMed ID: 33496366 [TBL] [Abstract][Full Text] [Related]
60. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study. Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]